Scanlon Releases Reports Showing How Inflation Reduction Act Will Lower Health Care Costs for PA-05 Families
Washington, September 2, 2022
Chester, PA — Congresswoman Mary Gay Scanlon (PA-05) today announced that families in Pennsylvania’s 5th Congressional District will soon see more affordable prescription drugs for Medicare recipients and lower health insurance premiums made possible by the Inflation Reduction Act.
“For too long, families in PA-05 have been forced to choose between paying for life-saving medication or insurance coverage and putting food on the table,” said Rep. Scanlon. “The Inflation Reduction Act takes major steps to rein in out-of-control health care costs – finally empowering Medicare to negotiate lower drug prices and, for the first time ever, capping Medicare Part D out-of-pocket drug spending at $2,000. Best of all, it is fully paid for by ensuring that big corporations pay their fair share of taxes while ensuring that middle-class Pennsylvanians and small businesses don't pay a cent more.”
The Inflation Reduction Act will make health care more affordable for PA-05 families by:
The Inflation Reduction Act will lower prescription drug costs for PA-05 families by:
The urgent need for these reforms is demonstrated by Committee on Oversight and Reform’s landmark drug pricing investigation, which reveals how the pharmaceutical industry’s uninhibited pricing practices lead to price gouging and runaway costs for Americans.
Find the report on the benefits of the Inflation Reduction Act health coverage provisions for PA-05 residents here.
Find the report on the benefits of the Inflation Reduction Act Medicare drug pricing provisions for PA-05 residents here.
Washington, DC Office
1227 Longworth House Office Building
Washington, DC 20515
Phone: (202) 225-2011
2501 Seaport Drive, BH230
Chester, PA 19013
Phone: (610) 626-2020